论文信息 - Suivi et prise en charge des troubles endocriniens en post-greffe de cellules souches hématopoïétiques : insuffisance corticotrope et ostéoporose - 字舞流文

Suivi et prise en charge des troubles endocriniens en post-greffe de cellules souches hématopoïétiques : insuffisance corticotrope et ostéoporose

C. Decanter | M. Vantyghem | I. Yakoub-Agha | R. Duléry | S. François | J. Cornillon | E. Berranger | F. Bauters | A. Marçais | R. Tabrizi | M. Couturier | N. Maillard | E. Hermete

[1] R. Kamble,et al. Systemic effects of oral budesonide in hematopoietic transplant: implications of drug interaction with azoles , 2012, Bone Marrow Transplantation.

[2] M. Aljurf,et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. , 2012, Biology of Blood and Marrow Transplantation.

[3] L. Hofbauer,et al. Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: Report from the Consensus Conference on Clinical Practice in chronic graft‐versus‐host disease , 2011, Transplant international : official journal of the European Society for Organ Transplantation.

[4] Y. Chae,et al. Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients , 2009, Bone Marrow Transplantation.

[5] P. McCarthy,et al. High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy , 2008, Bone Marrow Transplantation.

[6] B. Brennan,et al. Endocrine late effects after bone marrow transplant. , 2002, British journal of haematology.

[7] K. Sullivan,et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.